Andrew H Del Matto sold $2.6M of NTSK
Chief Financial Officer at Netskope Inc. 149,210 shares at an average of $17.20, traded Dec 31, 2025, filed Jan 5, 2026.
Score components
- +22RoleCFO
- +25Trade size$2.6M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -23.6%, 3m -44.7%, 6m -28.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001288241-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | CConversion Class A Common Stock | +33,387 | - | - | 74,880 | Jan 5, 2026 |
| Dec 31, 2025 | SOpen-market sale Class A Common Stock | -33,387 | $17.67 | $590k | 41,493 | Jan 5, 2026 |
| Jan 2, 2026 | CConversion Class A Common Stock | +77,207 | - | - | 118,700 | Jan 5, 2026 |
| Jan 2, 2026 | SOpen-market sale Class A Common Stock | -77,207 | $16.92 | $1.3M | 41,493 | Jan 5, 2026 |
| Jan 5, 2026 | CConversion Class A Common Stock | +38,616 | - | - | 80,109 | Jan 5, 2026 |
| Jan 5, 2026 | SOpen-market sale Class A Common Stock | -38,616 | $17.34 | $670k | 41,493 | Jan 5, 2026 |
| Dec 31, 2025 | MOption exercise Restricted Stock Unitsderivative | -329,566 | $0.00 | $0 | 329,566 | Jan 5, 2026 |
| Dec 31, 2025 | MOption exercise Class B Common Stockderivative | +329,566 | $0.00 | $0 | 411,864 | Jan 5, 2026 |
| Dec 31, 2025 | CConversion Class B Common Stockderivative | -33,387 | $0.00 | $0 | 378,477 | Jan 5, 2026 |
| Jan 1, 2026 | MOption exercise Restricted Stock Unitsderivative | -15,625 | $0.00 | $0 | 203,125 | Jan 5, 2026 |
| Jan 1, 2026 | AGrant or award Class B Common Stockderivative | +15,625 | $0.00 | $0 | 394,102 | Jan 5, 2026 |
| Jan 2, 2026 | CConversion Class B Common Stockderivative | -77,207 | $0.00 | $0 | 316,895 | Jan 5, 2026 |
| Jan 5, 2026 | CConversion Class B Common Stockderivative | -38,616 | $0.00 | $0 | 278,279 | Jan 5, 2026 |
Related signals
Other insiders at Netskope Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Netskope Inc | Lightspeed Venture Partners IX, L.P. owner | $158k 10,621 shares | -100% | |
| 51Moderate | Netskope Inc | Lightspeed Venture Partners Select, L.P. owner | $158k 10,621 shares | -100% | |
| 71Notable | Netskope Inc | William J.G. Griffith director, owner | $3.8M 306,399 shares | +50% | |
| 63Notable | Netskope Inc | ICONIQ Strategic Partners VIII Holdings, L.P. owner | $3.8M 306,399 shares | +50% | |
| 64Notable | Netskope Inc | William J.G. Griffith director, owner | $7.2M 610,291 shares | - | |
| 56Moderate | Netskope Inc | ICONIQ Strategic Partners VIII Holdings, L.P. owner | $7.2M 610,291 shares | - | |
| 65Notable | Netskope Inc | Lightspeed Venture Partners IX, L.P. owner | $2.8M 229,696 shares | -2163% | |
| 65Notable | Netskope Inc | Lightspeed Venture Partners Select, L.P. owner | $2.8M 229,696 shares | -2163% | |
| 75Notable | Netskope Inc | Arif Janmohamed director | $15M 1,650,000 shares | -100% | |
| 72Notable | Netskope Inc | Lightspeed Venture Partners IX, L.P. owner | $15M 1,650,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.